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a b s t r a c t
Pools of frozen biopsies from patients with squamous cell carcinoma (SCC) (n¼29) actinic keratosis (AK)
(n¼31), keratoacanthoma (n¼91) and swab samples from 84 SCCs and 91 AKs were analysed with an
extended HPV general primer PCR and high-throughput sequencing of amplimers. We found 273
different HPV isolates (87 known HPV types, 139 previously known HPV sequences (putative types) and
47 sequences from novel putative HPV types). Among the new sequences, ﬁve clustered in genus
Betapapillomavirus and 42 in genus Gammapapillomavirus. Resequencing of the three pools between 21
to 70 times resulted in the detection of 283 different known or putative HPV types, with 156 different
sequences found in only one of the pools. Type-speciﬁc PCRs for 37 putative types from an additional 296
patients found only two of these putative types. In conclusion, skin lesions contain a large diversity of
HPV types, but most appeared to be rare infections.
& 2013 Elsevier Inc. All rights reserved.
Introduction
More than 150 different human papillomavirus (HPVs) types
have been completely cloned, sequenced and given an ofﬁcial
number and the number of putative novel HPV types is continu-
ously growing (Bernard et al., 2010; Bottalico et al., 2011; Chen
et al., 2007a; Chen et al., 2007b; Chouhy et al., 2010; Ekstrom et al.,
2011; Ekstrom et al., 2010; Foulongne et al., 2012; Kohler et al.,
2011; Li et al., 2012; Nobre et al., 2009; Vasiljevic et al., 2008;
Vasiljevic et al., 2007). The oncogenic mucosal types of HPV cause
cervical cancer (Walboomers et al., 1999), as well as vulvar, anal
and penile cancer (IARC, 2007) whereas some cutaneous HPV
types cause skin warts and others are associated with develop-
ment of squamous cell carcinoma (SCC) in patients with the rare
immunosuppressive disease epidermodysplasia verruciformis
(Jablonska et al., 1972, 1997). Several cutaneous HPV types are
commonly found in different skin lesions such as squamous cell
carcinoma (SCC) (Asgari et al., 2008; Harwood et al., 2004), actinic
keratosis (AK) (Mackintosh et al., 2009), and keratoacanthoma
(KA) (Forslund et al., 2003; Stockﬂeth et al., 1999) as well as on
healthy skin (Antonsson et al., 2000; de Koning et al., 2007, 2009;
Forslund et al., 2004), in both immunocompetent and immuno-
suppressive patients.
Classiﬁcation of papillomaviruses (PVs) is based on the
sequence of the major capsid protein gene L1, where the sequence
of a new HPV type should be o90% similar to the L1 gene in any
known type (de Villiers et al., 2004). Several general primer PCR
systems targeting the L1 gene can amplify a broad range of HPV
types (Berkhout et al., 1995; de Roda Husman et al., 1995; Forslund
et al., 1999, 2003; Gravitt et al., 2000; Harwood et al., 1999).
The general primer pair FAP59/64 ampliﬁes both genital and
cutaneous types within the HPV genera Alpha-, Beta- and
Gammapapillomavirus (Forslund et al., 1999).
Several different methods for type-speciﬁc HPV detection exist
(Forslund et al., 1994; Poljak et al., 1999; Schmitt et al., 2006;
Soderlund-Strand et al., 2008), notably PCR followed by hybridiza-
tion to type-speciﬁc probes coupled to ﬂuorescent beads (Michael
et al., 2011; Schmitt et al., 2011), type-speciﬁc PCR and general
primer PCR, followed by sequencing (Berkhout et al., 1995; Chouhy
et al., 2010; Ekstrom et al., 2010; Forslund et al., 2007).
Previously, we found that high throughput sequencing of
amplimers obtained using FAP59/64 revealed an extended diver-
sity of HPV types (Ekstrom et al., 2011). In this study, we used
bidirectional sequencing using the recently developed 454 Tita-
nium chemistry to investigate if the detection of HPV sequences
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could be improved. In addition, we wished to investigate if the
new HPV sequences were commonly present in samples from
different skin lesions. The pooled PCR products were puriﬁed
using MinElute PCR Puriﬁcation kit (Qiagen), and sequenced using
a 454 GS Junior (Roche, Mannheim, Germany).
Results
Identiﬁcation of known and previously unknown HPV sequences
The analyses of the three different sample pools with different
set of primer combinations identiﬁed 273 (228 with FAP and
90 with the novel primer combinations) different HPV types or
putative types out of which 87 (76 detected with FAP and 33 with
novel primer combinations) were known HPV types, 139 (117
detected with FAP and 45 with novel primer combinations)
sequences from previously known putative HPV types and
47 (35 with FAP and 12 with novel primer combinations) subgenomic
sequences putatively representing novel types (Tables 1 and 2). In
a recent report we identiﬁed 44 subgenomic sequences from novel
putative HPV types, designated SE1 to SE44, of lengths varying
from 84 to 450 bp (Ekstrom et al., 2011). In the present study, we
used bidirectional sequencing with the GS FLX Titanium chemistry
and obtained much longer sequences than in the previous study
(mean read length 395 base pairs, compared to 230 base pairs in
our previous study). The longer sequences revealed that seven
of the previously reported subgenomic SE sequences belonged to
the same virus as other SE sequences (SE4¼SE27; SE13¼SE36;
SE17¼SE43; SE18¼SE29¼SE37; SE20¼SE44; and SE31¼SE33).
Sequences SE2, SE6, SE8, and SE21, which were considered as
preliminary in the previous publication because of insertion/
deletion errors causing premature stop codons in the L1 ORF
(Ekstrom et al., 2011), were detected again, but now with more
high quality sequences that did not contain premature stop
codons. Out of the other 37 SE types detected in the previous
study, 33 with FAP and 13 with novel primer combinations were
detected again (Table 2). For 17 of these sequences (SE2, 3, 4, 8, 12,
13, 17, 18, 24, 25, 33, 34, 35, 38, 39, 41 and 42), we obtained longer
sequences. The longer SE38 sequence was found to overlap with
the subgenomic sequence GC04, previously described by Chouhy
et al. (2010).
For 33 of the 47 novel putative HPV types detected in this study
we obtained 4331 bp (range 331–444 bp and mean 436 bp) and
for the 14 additional sequences we obtained a sequence from
either the 5′-end (n¼10, 141–363 bp, and mean¼262 bp) or the
3′-end of the amplimer (n¼4, 222–225 bp, and mean¼224 bp)
(Table 1).
The pool with swab samples from SCCs and AKs contained
most of the sequences from known/putative HPV types (n¼163)
closely followed by the biopsies from KAs (known/putative HPV
types: n¼150), both pools contained similar number of novel
putative HPV types (n¼24) (Table 1). The majority of the known
HPV sequences found belonged to HPV types in genus Gammapa-
pillomavirus (n¼128), followed by genus Betapapillomavirus
(n¼73) and genus Alphapapillomavirus (n¼25) (Table 1). Based
on the genera of the closest hit in BLAST, most of the novel
putative HPV types also belonged to the genus Gammapapilloma-
virus (n¼42), ﬁve sequences belonged to genus Betapapilloma-
virus and none to genus Alphapapillomavirus.
Resequencing
The three sample pools (A, B and C) were resequenced using
121 different multiplex identiﬁers (MIDs).
An adjusted value for the number of reads from each MID was
calculated by multiplying the number of reads for each MID with
the number of MIDs used in that particular MID-pool, i.e. 21, 30, 35
and 35. The average adjusted number of reads was 77305 (median
71,820 and range 21,595–280,000). One MID that generated only
3605 reads was considered inadequate and was excluded.
Altogether sequences from 283 different known and putative
HPV types were detected. Sample A (fresh frozen biopsies from 29
SCCs and 31 AKs) was resequenced using 30 different MIDs.
Sequences from 93 known and putative HPV types were detected,
but only three types were detected by all the 30 MIDs (Table 3).
Twenty types/putative types were detected by more than 50% of
the analyses. Sample B (fresh frozen biopsies from 91 KAs) was
resequenced using 70 different MIDs in two separate sequencing
runs. In total, 198 known and putative HPV types were detected
(Table 3). Sequences from 59 HPV types/putative types were
detected by more than half of the resequencing, but only six types
were detected in all 70 MIDs. Pool C (swab samples from the top of
84 SCCs and 91 AKs) was resequenced with 21 different MIDs. In
Table 1
Number and genera of HPV sequences found.
Sample Primers Known HPV sequences Novel HPV sequencesa Genera of
known HPV
sequencesd
Genera
of novel
putative
HPV
typesd
HPV types FA types FAIMVS SE types Complete
fragmenta
Partial, 5′ Partial, 3′ α β γ β γ
Frozen biopsies from 29 SCCsb and 31 AKsb FAP59/FAP64 36 31 3 10 4 1 0 1 47 32 1 4
Novel
primers
13 11 0 0 1 0 0 0 13 11 0 1
Frozen biopsies from 91 KAsb FAP59/FAP64 63 50 7 21 13 6 3 23 43 75 2 20
Novel
primers
12 13 0 3 2 0 0 1 13 14 0 2
Swab samples from 84 SCCs and 91 AKs FAP59/FAP64 46 62 6 24 9 5 1 2 55 80 1 14
Novel
primers
26 17 2 10 9 0 0 0 35 20 2 7
All samplesc 87 91 8 40 33 10 4 25 73 128 5 42
a 4400 bp sequences represent an almost complete or a complete FAP amplimer. Partial sequences may map to either the 5′ or the 3′ of the FAP amplimer.
b SCC¼squamous cell carcinoma, AK¼actinic keratosis, and KA¼keratoachantoma.
c As sequences were found in more than one of the pools the sum of the sequences is less than the total number of sequences.
d Genera based on the top hit sequence in BLAST.
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Table 2
A list of HPV sequences found.
Known HPV sequences Known putative sequences (FA, FAIMVS and SE types) Novel putative HPV sequences
Name Genus Found in patient
groupa
Found with novel
primers
Name Genus Found in patient
groupa
Found with novel
primers
Name Genus Found in patient
groupa
Found with novel
primers
HPV 2 Alpha B FA1.1 Gamma C SE48 Beta B
HPV 3 Alpha B FA2.1 Gamma C SE49 Gamma A, C
HPV 4 Gamma B FA6 Gamma A, C C SE50 Gamma B
HPV 5 Beta A, B, C A, B, C FA8 Gamma B, C SE51 Gamma B, C
HPV 6 Alpha B FA9 Gamma A, C SE52 Gamma B
HPV 8 Beta A, C A, C FA10 Gamma B, C SE53 Gamma C
HPV 9 Beta A, B, C FA11 Gamma B B, C SE54 Gamma B
HPV 10 Alpha B B FA12.2 Gamma B, C SE55 Gamma C
HPV 11 Alpha B FA13 Gamma A, B, C SE56 Beta A
HPV 12 Beta A, B, C FA14 Beta A, B, C C SE57 Gamma C
HPV 14 Beta A, B, C A, C FA15 Gamma B C SE58 Gamma B
HPV 15 Beta C C FA20.2 Gamma A SE59 Gamma B
HPV 16 Alpha B FA20.3 Gamma B, C B SE62 Gamma C
HPV 17 Beta A, B, C C FA23.3 Beta C SE63 Gamma C
HPV 18 Alpha B FA24.2 Gamma B, C A SE64 Gamma A
HPV 19 Beta A, B, C B FA25 Beta B, C SE65 Gamma B
HPV 20 Beta A, B, C FA27 Gamma A, C SE67 Gamma C
HPV 21 Beta A, B, C FA28 Gamma B, C SE68 Beta B, C
HPV 22 Beta B A, C FA31 Gamma A, B, C SE69 Gamma C
HPV 23 Beta A, B, C FA32 Gamma C SE70 Gamma B, C
HPV 24 Beta C FA34 Gamma A, B, C SE71 Gamma B
HPV 25 Beta C FA35 Gamma A, B, C SE72 Gamma B, C
HPV 27 Alpha B FA38 Gammab C SE73 Gamma B
HPV 28 Alpha B FA39 Beta C SE74 Gamma C
HPV 31 Alpha B FA40 Beta A, B, C SE75 Gamma A, B
HPV 33 Alpha B FA41 Gamma B, C SE77 Gamma C
HPV 35 Alpha B FA44 Gamma B SE78 Gamma C
HPV 36 Beta A, C FA45 Gammab A, B, C SE79 Gamma A
HPV 37 Beta A, B, C FA46 Gamma A, B, C SE80 Gamma B
HPV 38 Beta A, B, C B, C FA48 Gamma A, C SE81 Gamma B
HPV 45 Alpha B FA54 Gamma B, C SE82 Gamma B
HPV 47 Beta C FA57 Gamma B, C SE83 Gamma B
HPV 48 Gamma C FA60.1 Beta C SE84 Gamma B
HPV 49 Beta A, B, C FA61 Gamma B SE85 Gamma B
HPV 50 Gamma A, B, C FA62 Gamma A A SE86 Gamma B
HPV 51 Alpha B FA64 Gamma B, C SE117 Gamma C
HPV 52 Alpha B FA65 Gamma B, C A SE118 Gamma C
HPV 56 Alpha B FA66 Gamma B B SE119 Gamma C
HPV 57 Alpha C FA67 Gamma A, B, C SE120 Gamma C
HPV 58 Alpha B FA68 Gamma B, C SE121 Gamma C
HPV 59 Alpha B FA69 Gamma A, B SE122 Beta C
HPV 66 Alpha B FA70 Beta A SE123 Gamma C
HPV 68 Alpha C FA73 Gamma B SE124 Gamma C
HPV 73 Alpha B FA77 Gammab C SE125 Beta C
HPV 75 Beta A FA81 Gamma A, B, C SE126 Gamma A
HPV 76 Beta A, B, C FA86 Gamma C SE127 Gamma B
HPV 77 Alpha B FA87 Gamma C SE128 Gamma B
HPV 80 Beta A, B, C C FA88 Gamma A, C A
HPV 82 Alpha B FA89 Gamma A, B, C B
HPV 92 Beta A, B, C FA90 Gamma B
HPV 93 Beta B, C FA92 Gamma B
HPV 94 Alpha A, B FA95 Gamma C
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HPV 96 Beta A, C A FA100 Gamma B
HPV 98 Beta A, B, C FA101 Gamma B, C
HPV 99 Beta A, C FA105 Gamma B
HPV 100 Beta A, B, C B FA107.1 Gamma B
HPV 104 Beta A, B, C A, C FA108 Beta B, C
HPV 105 Beta A, B, C A, C FA109 Gamma A, B, C
HPV 107 Beta A, B, C C FA111 Gamma B, C B
HPV 110 Beta B, C C FA112 Beta A, C
HPV 111 Beta A, C A, C FA114 Beta A, C
HPV 115 Beta B B, C FA115 Gamma B, C
HPV 118 Beta A, B, C FA117 Gamma C
HPV 119 Gamma B FA118 Beta A, B, C C
HPV 120 Beta A, B, C B, C FA119 Beta A, B, C
HPV 121 Gamma C FA120 Gamma B
HPV 122 Beta A, B, C B, C FA121 Gamma A, B, C
HPV 123 Gamma B, C FA124 Beta B, C
HPV 124 Beta A, B, C A, B, C FA127 Beta A, B, C B
HPV 128 Gamma B, C FA126 Beta A
HPV 130 Gamma A, B, C A, B, C FA128 Beta A, C
HPV 131 Gamma B, C FA131 Betab A, B, C
HPV 132 Gamma B, C FA132 Beta A, B, C A, B
HPV 133 Gamma B FA133 Gamma C
HPV 134 Gamma A, B, C FA138 Gamma B
HPV 143 Beta C FA141 Beta A, C
HPV 147 Gamma A, C FA142 Gamma A, C
HPV 148 Gamma A, C FA145 Gamma C
HPV 150 Beta A, B, C FA148 Gamma C
HPV 151 Beta A, B, C FA149 Beta B, C
HPV 153 Gamma C FA152 Gamma C
HPV 156 Gamma B FA153 Gamma C
RTRX7 Beta C FA156 Gamma C
HPV isolate 915 F 06 005
FS1
Gamma B FA159 Gamma B, C
HPV isolate 915 F 06 002
KN1
Gamma A FA160 Gamma B, C B, C
HPV isolate 915 F 06 002
KN2
Gamma A, C FA162 Betab A, B, C C
HPV isolate 915 F 06 002
KN3
Gamma C FA166 Gamma A
FA168 Beta A, C
FA170 Gamma B, C
FA173 Gamma C
FAIMVS4 Gamma B, C
FAIMVS6.2 Beta C
FAIMVS7 Gammab A, B, C
FAIMVS8 Gamma B
FAIMVS9 Gamma B, C
FAIMVS11.2 Betab A, B, C
FAIMVS13.2 Betab B, C C
FAIMVS15 Gammab A, B, C
SE1 Gamma C
SE2 Gamma C
SE3 Gamma A, C
SE4 Gamma A, C
SE5 Gamma B
SE6 Gamma B
SE7 Gamma A, B
SE8 Gamma B
SE9 Gamma B B
SE10 Gamma B
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Table 2 (continued )
Known HPV sequences Known putative sequences (FA, FAIMVS and SE types) Novel putative HPV sequences
Name Genus Found in patient
groupa
Found with novel
primers
Name Genus Found in patient
groupa
Found with novel
primers
Name Genus Found in patient
groupa
Found with novel
primers
SE11 Gamma B, C
SE12 Gamma B, C
SE13 Gamma B, C
SE14 Gamma C
SE16 Gamma A, B, C
SE17 Gamma C
SE18 Gamma A, B, C
SE20 Gamma C
SE21 Gamma A, B, C B
SE22 Beta B, C C
SE23 Beta A, B, C
SE24 Gamma C
SE25 Gamma B
SE26 Gamma A, B C
SE28 Gamma A, C
SE30 Gamma C
SE33 Beta A, C C
SE34 Gamma B
SE35 Gamma B, C
SE38 (GC04) Gamma B, C
SE39 Gamma B, C
SE41 Gamma B, C
SE42c Gamma C C
SE56 Beta C
SE57 Gamma C
SE63 Gamma C
SE68 Beta C
SE75 Gamma C
SE80 Gamma B
SE87 Gamma C
Chimpanzee PV
CAA8
Betab B
a A¼ frozen biopsy from squamous cell carcinomas (SCCs) or actinic keratoses (AKs), B¼frozen biopsy from keratoacanthomas and C¼swab samples from SCCs or AKs.
b Genera based on closest relative with an assigned genus.
c SE42 has been cloned and completely sequenced and is now named HPV 155.
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total, sequences from 174 HPV-types (including known and putative
HPV types) were detected (Table 3) of which 90 were detected by
more than half of the resequencings. Sequences from 57 different
HPV types/putative types were detected by all the
21 MIDs in the resequencing. In total 55 different sequences were
detected in all three pools, 72 different sequences were detected in
two of the pools and 156 different sequences in only one of the pools.
Phylogenetic analysis
Phylogenetic relationships between the 73 putative novel HPV
types in the “SE-series” (found using 454 sequencing of FAP and
novel primer combinations amplimers, 31 of which were reported
previously (Ekstrom et al., 2011)), complete, nearly complete
fragments or 4200 bp containing the 5′-end, and representative
known PV types from all other genera found that 65 of the SE
sequences cluster with HPV types of the genus Gammapapilloma-
virus and eight within the genus Betapapillomavirus (Fig. 1).
Typing of SE sequences using Luminex
Sequence-speciﬁc probes for SE sequences 1–44 were used to
investigate the prevalence of these sequences in various skin
samples. As described above, some of these SE sequences were
now found to belong to the same virus. Among the 37 unique SE
sequences, 17 were detected in the Luminex analysis of the
samples included in the pool where these sequences had originally
been detected (Table 4). The SE sequences were mostly detected
Table 3
Repeatable detection of HPV types in the resequencings.
HPV sequences detected in
resequencing of Pool A
Proportion
of
sequencings
positive (%)
HPV sequence detected in
resequencing of Pool B
Proportion
of
sequencings
positive (%)
HPV sequence detected in
resequencing of Pool C
Proportion
of
sequencings
positive (%)
HPV24, HPV108, HPV130 100 HPV38, HPV98, HPV134, FA89,
FA111, SE21
100 HPV5, HPV8, HPV9, HPV12, HPV14,
HPV19, HPV20, HPV21, HPV23, HPV37,
HPV38, HPV49, HPV76, HPV98, HPV104,
HPV105, HPV107, HPV120, HPV122,
HPV123, HPV124, HPV130, HPV134,
HPV136, HPV142, HPV145, HPV146,
HPV147, HPV151, HPV isolate cat/EAA/
USA/2001, HPV isolate SIBX8, FA14, FA24,
FA26, FA34, FA39, FA41, FA65, FA89,
FA98, FA118, FA126, FA127, FA141, FA142,
FA160, FA162, FAIMVS6, FAIMVS13,
FAIMVS15, SE17, SE22, SE23, SE32, SE39,
SE40, SE41
100
HPV12, HPV14, HPV23, HPV76,
HPV124, FA26, FA37, SE16, SE28
475–99 HPV5, HPV9, HPV12, HPV14, HPV19,
HPV20, HPV49, HPV80 HPV105, HPV110,
HPV120, HPV122, HPV124, HPV133,
HPV136, HPV139, HPV147, FA20, FA24,
FA41, FA57, FA66, FA81, FA98, FA101,
FA107, FA118, FA127, FA132, FA155,
FA160, FAIMVS7, FAIMVS15, SE6, SE7,
SE13, SE32
475–99 HPV17, HPV50, HPV80, HPV96, HPV110,
HPV isolate P5-58, FA12, FA32, FA57,
FA101, FA132, FAIMVS11, SE4, SE16, SE28,
SE38, SE49, SE68
475–99
HPV5, HPV9, HPV8, HPV49, HPV50,
FAIMVS11, FAIMVS15, SE18
450–75 HPV17, HPV21, HPV107, HPV151, FA11,
FA34, FA46, FA54, FA65, FA90, FA115,
FA126, SE9, SE16, SE25, SE71
450–75 HPV24, HPV100, HPV111, HPV132,
HPV150, FA3, FA6, FA38, FA121, FA129,
FA152, FAIMVS7, SE20, SE33, SE67
450–75
HPV25, HPV80, HPV96, HPV120,
HPV145, FA1, FA34, FA119, FA127,
FA131, FA149, HPV isolate cat/EAA/
USA/2001, SE21
425–50 HPV4, HPV23, HPV37, HPV50, HPV100,
HPV135, HPV138, HPV141, HPV isolate
P5-58, FA15, FA18, FA45, FA53, FA72,
FA73, FA131, FA159, FAIMVS9, FAIMVS13,
SE5, SE10, SE12, SE28, SE34, SE65, SE72,
SE86
425–50 FA10, FA148, FA153, FA23, FA25, FA45,
FA46, FA86, FA9, FAIMVS4, HPV92, SE11,
SE24, SE51, SE70
425–50
HPV17, HPV19, HPV21, HPV36, HPV38,
HPV75, HPV92, HPV94, HPV99,
HPV100, HPV104, HPV105, HPV111,
HPV122, HPV134, HPV142, HPV147,
HPV150, HPV151, HPV isolate
B52_FAB, HPV isolate GC05, HPV
isolate GC10, HPV isolate GC15, HPV
isolate P5-60, FA6, FA9, FA14, FA27,
FA35, FA39, FA45, FA46, FA48, FA62,
FA70, FA74, FA109, FA112, FA118,
FA121, FA124, FA126, FA128, FA132,
FA142, FA162, FA81, FA89, FAIMVS7,
SE3, SE4, SE23, SE26, SE33, SE40,
SE49, SE56, SE64, SE75, SE79
40–25 HPV2, HPV3, HPV6, HPV8, HPV10, HPV11,
HPV16, HPV18, HPV22, HPV24, HPV27,
HPV28, HPV31, HPV33, HPV35, HPV45,
HPV51, HPV52, HPV56, HPV58, HPV59,
HPV66, HPV68, HPV68, HPV73, HPV76,
HPV77, HPV92, HPV96, HPV104, HPV123,
HPV130, HPV131, HPV142, HPV146,
HPV150, Feline papillomavirus,
Chimpanzee papillomavirus isolate
CAA8, HPV isolate B2-GP, HPV isolate 915
F 06 005 FS1, HPV isolate BA10 L1, HPV
isolate GC12_1, FA1, FA2, FA7, FA9, FA10,
FA12, FA14, FA22, FA23, FA25, FA27, FA36,
FA40, FA44, FA51, FA61, FA64, FA68, FA69,
FA78, FA88, FA92, FA100, FA105, FA108,
FA109, FA114, FA116, FA119, FA120,
FA121, FA138, FA142, FA158, FA162,
FAIMVS4, FAIMVS6, FAIMVS8, SE8, SE11,
SE15, SE18, SE22, SE23, SE26, SE35, SE38,
SE39, SE41, SE48, SE50, SE51, SE54, SE58,
SE59, SE61, SE62, SE66, SE68, SE70, SE73,
SE75, SE76, SE80, SE81, SE82, SE83, SE84,
SE85
40–25 HPV15, HPV24, HPV38, HPV57, HPV68,
HPV99, HPV121, HPV131, HPV135, Feline
papillomavirus, HPV isolate RTRX7, FA1,
FA2, FA8, FA16, FA20, FA27, FA37, FA48,
FA51, FA52, FA54, FA60, FA64, FA68, FA77,
FA81, FA87, FA88, FA95, FA108, FA109,
FA111, FA112, FA117, FA119, FA122, FA128,
FA131, FA133, FA134, FA135, FA145,
FA150, FA156, FA158, FA159, FAIMVS9,
FAIMVS14, FANIMVS17, SE1, SE2, SE3,
SE12, SE13, SE21, SE35, SE53, SE55, SE57,
SE60, SE61, SE62, SE63, SE69, SE72, SE74,
SE77, SE78
40–25
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only in a single sample, the exception being SE41 that was
detected in ﬁve samples. Fourteen of the 17 SE sequences were
found in swab samples, two SE sequences in biopsies, and one SE
sequence in both swab samples and a biopsy. For two of the
sequences that were corrected in the present paper (SE21 and
SE29), there was a mismatch between the corrected template
sequence and the probe, which could explain why these sequences
were not detected.
Fig. 1. Maximum likelihood tree based on 42 of the novel putative SE sequences identiﬁed in this study with complete or almost complete fragments or 4200 bp containing
the 5′-end, 31 SE sequences from the previous study (Ekstrom et al., 2011) and L1 from representative known PV types from all other genera.
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Luminex testing of the additional 592 skin samples for the
44 SE sequences found only two sequences (SE16 in one tumour
biopsy from a patient with AKs and in one biopsy from normal
skin from a BCC patient, and SE41 in one BCC tumour sample).
Discussion
We ﬁnd that the human skin harbours a large spectrum of
different HPV types and that there is reason to believe that a
substantial number of HPV types remains to be detected. In this
study, we analysed samples that had previously been analysed for
the presence of HPV with both conventional and 454 sequencing
(Ekstrom et al., 2011; Forslund et al., 2003, 2007, 2004). Never-
theless, we managed to identify 35 subgenomic sequences from
novel putative HPV types, which had previously not been detected,
by simply using a more modern version of the 454 sequencing
method. In order to detect a broader number of HPV types, we also
designed novel primer combinations. Two of the novel PCR
reactions were speciﬁcally designed to detect HPVs form the
genera Mu and Nu, which are rather distantly related to other
HPV genera and contain only a few types. As all the 12 new
putative HPV types detected clustered in the Beta- and Gamma-
papillomavirus genera, it appears that these genera have a
particularly high genomic diversity. Chouhy et al. (2010) have
speculated that the HPV general primer system FAP may have
reached its limit in detecting new viruses, but our results show
that by using updated 454 sequencing, even HPV types present in
low copy numbers (that probably would otherwise be missed in
the cloning step) can be found. Thus, the high throughput
sequencing technology appears to be useful in the continuing
efforts to obtain the complete picture of the HPV types that are
present in humans.
The mean read-length for 454 GS Junior using titanium
chemistry is approximately 400 bases, depending on the sample
and genomic characteristics. Using bidirectional sequencing, a
complete FA fragment of approximately 440 bp could be obtained.
For most of the subgenomic sequences from putative novel types
(33/47), the complete or almost complete FA fragment was
obtained. The 14 shorter sequences could be the result of DNA
breakage or may have been trimmed in the bioinformatics step
that removed low quality sequences.
With increasing sensitivity and throughput of the sequencing
technology, there is a substantial risk to obtain artifactual “chi-
meric” sequences that are actually composed of sequences from
different viruses. Genomic recombination has been described for
cetacean papillomaviruses (Robles-Sikisaka et al., 2012). Even
though this has not been described for HPVs, multiple co-
infections of related microorganisms can result in recombinations
(Liu et al., 2010). Both naturally occurring genomic recombinations
and PCR mediated recombinations may mislead phylogenetic
analysis (Liu et al., 2010). Our bioinformatics pipeline has been
trained to automatically detect and remove putative chimeras,
which may have resulted from PCR-mediated recombination
between related templates. However, manual checking still found
ﬁve sequences that were likely chimeras. For all of these ﬁve
sequences the part of the sequence that appeared to have a
different phylogenetic origin was too short to be found by our
pipeline. Although we checked the sequences for possible chi-
meras both automatically and manually, the possibility still exists
that some chimeric sequences may have escaped detection. For
construction of the phylogenetic tree we used only the sequences
validated to not represent chimeras.
The majority of HPV types and putative types detected
belonged to the genera Beta- and Gammapapillomavirus, but 25
mucosal types from genus Alphapapillomavirus were also found.
Previous studies have also reported on the presence of anogenital
oncogenic HPV types in skin samples (Asgari et al., 2008; Iftner
et al., 2003). Contamination of the skin by viruses originating
from mucosal surfaces, mediated by the ﬁngers has been
reported (Alam et al., 2003). We took the biopsies from SCCs
and AKs after tape-stripping the skin surface (Forslund et al.,
2004), to reduce the probability of detecting contaminating
viruses. In the biopsies that had been cleansed with tape-
stripping, we found only a single Alphapapillomavirus-type of
HPV (HPV 94), suggesting that the presence of HPV94 in this
specimen did represent an infection.
Phylogenetically, all the SE sequences were classiﬁed into the
genera Beta- and Gammapapillomavirus, with the majority (65/73),
among the Gammapapillomavirus types. The genus Gammapapil-
lomavirus has been growing rapidly, now comprising at least 58
completely sequenced HPV types and approximately 178 putative
HPV types (among them 99 SE sequences) (Bernard et al., 2010;
Bottalico et al., 2011; Chen et al., 2007a; Chen et al., 2007b;
Ekstrom et al., 2011; Ekstrom et al., 2010; Foulongne et al., 2012;
Kohler et al., 2011; Li et al., 2012; Nobre et al., 2009 and
unpublished observations). The genus Gammapapillomavirus has
a large genetic diversity and many of the SE sequences form
clusters outside the previously deﬁned species. Also the genus
Betapapillomavirus is a diverse genus with 47 completely
sequenced HPV types and approximately 38 putative HPV types
(among them 9 SE sequences) (Bernard et al., 2010; Bottalico et al.,
2011; Chouhy et al., 2010; Ekstrom et al., 2011; Kohler et al., 2011;
Vasiljevic et al., 2008, 2007). Including the sequences reported in
this study, there is now evidence to suggest that 4300 different
cutaneous HPV types exist.
Only 17 of the 44 SE sequences could be detected in the
Luminex-based testing of the same samples where these sequences
had originally been found by the 454 sequencing. Possible reasons
include low copy numbers and/or mismatches to the PCR primer
sequences. The proportion of specimens testing positive for
these viruses precludes conclusions about their possible disease-
association. However, it is noteworthy that although we tested a
large number of swabs and biopsies from healthy skin only a single
healthy skin biopsy was positive for these viruses. Because design
and validation of a large number of type-speciﬁc probes for
Table 4
Results of the Luminex analysis of the presence of the 44 SE sequences in the
sample pools where the sequences were originally detected (Ekstrom et al., 2011).
SE type Luminex-conﬁrmed origin of SE
sequence according to diagnosis
and sample type
SE9 1 KA biopsy
SE10 1 SCC swab
SE13 1 SCC swab
SE15 1 SCC swab, 1 AK swab
SE17 1 SCC swab, 1 AK swab
SE19 1 SCC swab, 1 AK swab
SE20 1 SCC swab
SE22 1 SCC swab
SE23 1 SCC swab
SE25 1 SCC swab
SE28 1 AK biopsy
SE32 1 SCC swab, 1 AK swab
SE38 1 SCC swab
SE39 1 SCC swab
SE40 1 SCC swab
SE41 2 SCC swab, 2 AK swab, 1 KA biopsy
HPV155 (SE42) 1 SCC swab
SE27, SE29, SE31, SE36, SE37,
SE43, SE44
Deleted, found to be identical
to other SE sequence.
SE1–SE8, SE11, SE12, SE14, SE16, SE18,
SE21, SE24, SE26, SE30, SE33–35
Not detected
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Luminex is costly and time-consuming and the sensitivity of
Luminex detection appeared to be considerably less than the 454
sequencing, we considered that repeat high-throughput sequencing
will probably be the best method for continuing epidemiological
studies on the role of different HPV types in skin lesions.
The use of multiplex identiﬁers (MIDs) allows for the separa-
tion of individual samples from each other in a single sequencing
run. We obtained sequencing data from 121 different MID-
adaptors in a resequencing of the three sample pools. The
resequencing provided a clear distinction between those HPV
types that were detected by all MIDs and are probably present at
high copy numbers and those HPV types that were only picked up
by a few of the MIDs and are therefore probably present at a much
lower abundance. Four of the six SE types that clustered with the
Betapapillomavirus types in the phylogenetic tree were detected
in more than half of the analyses whereas only 15 of the 55 SE
types clustered within the genus Gammapapillomavirus.
In conclusion, we demonstrate that preampliﬁcation by general
primer PCR followed by bidirectional high throughput sequencing is
effective for detection of a very large number of HPV types present in
skin samples, including a large number of sequences that had
previously have not been described. The continuing improvements
of the sequencing technology are likely to continue to reveal an
extraordinary and expanding diversity of cutaneous HPVs.
Methods and Materials
Patients
Samples were collected from immunocompetent patients with
SCC (n¼119), AK (n¼114), basal cell carcinoma (BCC) (n¼117),
keratoacathoma (KA) (n¼8), seborrhoeic keratosis (n¼46) and
two other benign lesions (one prurigo nodularis and one benign
hyperkeratotic skin lesion) attending Swedish and Austrian hospi-
tals (Forslund et al., 2007). Two swab samples from the top of the
lesion and from normal adjacent skin were collected by a pre-
wetted (0.9% NaCl), cotton-tipped swab that was rolled over the
lesion (within margins of the lesion) and suspended in 1 ml of
saline. From each lesion as well as from normal adjacent skin, a
2-mm punch-biopsy was taken. The biopsies were taken after tape-
stripping (Forslund et al., 2004). Three patients were excluded
(one patient was on immunosuppressive drugs, one patient had a
mixed tumour and for one patient the diagnosis of SCC could not be
conﬁrmed histopathologically). The DNA from the biopsies was
extracted using a phenol-free method and the swab samples were
extracted by freeze-thawing (Forslund et al., 1999)
An additional 92 biopsies from KAs in both immunosuppressed
and immunocompetent patients were collected at the Department of
Dermatology and Plastic Surgery at the Norwegian National Hospital
in Oslo, Norway. The DNA was extracted using the QIAamp DNA
Minikit (Qiagen, Hilden, Germany) (Forslund et al., 2003).
Informed consent was obtained from participants. The study
adhered to the declaration of Helsinki and was approved by the
Ethical Review Committees of Karolinska Institute and of Lund
University (Sweden), Medical University Vienna (Austria) and
Institutional Review Board in Oslo (Norway).
Sample preparation
The samples were ampliﬁed with the general primer pair FAP,
FAP59/64, as described previously (Forslund et al., 1999) using 5 ml
of each sample per reaction. For SCC and AK biopsies, only samples
that were HPV positive in a previous study (Forslund et al., 2007)
were used (SCC, n¼29 and AK, n¼31). A plasmid including the
sequence of HPV12 was used as a positive control and a sensitivity
of one copy per microlitre was found. The PCR amplimers were
pooled into three different pools: (A) fresh frozen biopsies from
29 SCC lesions and 31 AK lesions, (B) fresh frozen biopsies from 91
KA lesions and (C) swab samples from the top of the lesion from
84 SCCs and 91 AKs. The PCR products were puriﬁed using
MinElute PCR Puriﬁcation kit (Qiagen), pooled and sequenced
using a 454 GS Junior (Roche, Mannheim, Germany). Pool A and
C were sequenced in two runs each, one without the multiplex
identiﬁers (MIDs) and one using MIDs. Pool B was sequenced in
three runs, one without MIDs and two using MIDs. Twelve MIDs
(unique oligonucleotide sequence of 10 bases, part of the adaptor
sequence) were purchased from Roche and 120 additional MIDs
from IDT (Integrated DNA Technology, Leuven, Belgium).
Four DNA libraries were prepared according to the Rapid
library preparation method manual for GS Junior Titanium Series
(454 sequencing; Roche) using four different pools of MID-
adaptors. One pool of 21 MID-adaptors (MID numbers 12–32)
was ligated to skin pool C, another pool of 30 MID-adaptors (MID
numbers 33–62) was ligated to skin pool A and two pools of 35
MID-adaptors each (MID numbers 63–97 and 98–132 respectively)
were ligated to skin pool B. After library preparation, the four
libraries with the four different sets of MID-pools were sequenced
individually in four 454 GS Junior runs.
In order to investigate whether the broad detection of HPV types
by the FAP primers could be further improved, we aligned the FAP
primer sequences against all HPV sequences present in GenBank
and designed new primers that should be able to detect those HPV
types where the FAP primers had mismatches. For the forward
primer FAP6085 (Forslund et al., 2003), ﬁve additional primers were
found to be required to achieve an essentially complete coverage
of HPV types. These were FAP6085A CCWGAYCCHAATAARTTTGG
(designed to improve the detection of in particular Alphapapillo-
mavirus types), FAP6085B CCWGACCCHAATMRRTTTGC (improved
ﬁt to several HPV types in several genera), FAP6085C CCWGATC-
CHAACMRRTTTGC (improved ﬁt to several HPV types in several
genera), FAP6085D GCWGATCCHAATMRRTTTGC (optimal ﬁt to the
Mu type 1a), FAP6085E CCWAATCCHAATMCCTTTGC (optimal ﬁt to
the Nu type 41). For the reverse primer FAP64 (Forslund et al.,
1999), four additional primers were found to be required to achieve
adequate coverage of published types FAP64B CCWATGTCWVHCA-
TITCICCATC (improved ﬁt to several HPV types in several genera),
FAP64C CCWGTATCWVHCATITCICCATC (improved ﬁt to in particu-
lar some Alphapapillomavirus types), FAP64D CCWACATCWVHCA-
TITCICCATC (improved ﬁt to HPV73) and FAP64F CCWGTGTCWVH-
CATIGTICCGTC (Improved ﬁt to HPV88).
The novel primers were evaluated for ability to amplify
different plasmids representing the HPV types where an improved
detectability was predicted (HPV1a, 26, 41, 59, 63, 73, 88, 92, 96,
100, 109, 112, and 155). Human DNA from the placenta, 10 ng
(3300 copies), was also tested to assure that the primers did not
amplify human DNA.
After conﬁrming detection of at least 2 copies/ml of each
plasmid, the novel primers were combined together with the
original FAP6085 and FAP64 in three different reactions, reaction 1
(multiplex reaction for a broader detection of HPVs, including
FAP6085, FAP6085A, FAP6085B, FAP085C, FAP64, FAP64B, FAP64C,
FAP64D and FAP64F), reaction 2 (multiplex reaction optimized for
detection of HPV types belonging to the genus Mupapillomavirus,
including FAP6085C, FAP6805D, FAP64 AND FAP64B) and reaction
3 (reaction optimized for detection of the genus Nupapillomavirus,
including FAP6085E and FAP64B).
PCR ampliﬁcation was then performed on the three pools A, B
and C described above using 2 μl DNA in 50 μl reaction containing
1 Qiagen Multiplex PCR Master Mix Qiagen (Germany) and
0.2 μM of each primer. The thermal programme started with a pre-
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heat of 95 1C for 15 min, followed by 45 cycles at 94 1C 30 s,
46–48 1C 90 s, and 72 1C 90 s, with a ﬁnal extension at 72 1C for
10 min.
PCR products from each reaction were puriﬁed and sequenced
as described above. Each pool was sequenced separately, using
different MIDs for each PCR reaction.
Analysis of sequences
Ambiguous bases (with a Phred quality score less than 30,
equivalent to a base calling accuracy of 99.9% (1 error in 1000 bases)
(Ewing and Green, 1998)) and primer sequences were removed. Reads
with a length of more than 80 bases and less than 20% of ambiguous
bases were screened for similarity to human and bacterial DNA using
SAHHA2 software (Ning et al., 2001). Reads with at least 95% identity
over 75% of their length to human or bacterial DNA were removed.
Remaining sequences were processed for assembly of contiguous
sequences (contigs) using MIRA software (with the parameters
‘-job¼denovo,genome,accurate,454 454_SETTINGS -AL:mo¼40 -AL:
mrs¼98 -AL:egp¼yes -AS:ardct¼3 -CO:mrpg¼4 -CL:qcmq¼30 -CL:
bsqcmq¼60’) (Chevreux et al., 2004). All assembled contigs and
singletons were then compared against GenBank using the NCBI
BLASTn (reward for nucleotide match¼1; penalty of nucleotide
mismatch¼1; cost to open a gap¼0; cost to extend a gap¼2;
e-valuere4). Sequences that over their length had different degrees
of similarity to the most closely related sequence in GenBank were
considered as “possible chimeras”, i.e. artifacts possibly containing
sequences originating from different viruses. The sequence that
aligned to its most closely related sequence in GenBank was divided
into three equal segments. If at least one of the segments had less
than 90% similarity and at least one had more than 90% similarity, as
well as if the difference between these segments by similarities to
corresponding overlapping parts was more than 5% (for example if
segment 1 was 88% similar and segment 2 was 94% similar) the
sequence was considered as “possible chimera” and excluded from
further analysis. If there was less than 5% difference between the
above described segments by similarities to corresponding overlap-
ping parts (for example segment 1 was 89% similar and segment
2 was 93% similar) the sequence was checked by manual BLASTn
analysis of whether the sequence had an approximately equal
frequency of nucleotide matches to its top blast hit across the
overlapping part.
If part of the selected sequences (4¼30 bases) did not overlap
to the top hit in the GenBank search, the sequence was cut and
blasted again to NCBI nucleotide database. If the top blast hit of
these cut sequences was different from the top blast hit of the
other part and/or the difference between their per cent identities
were 4¼10%, the sequence was also considered as “possible
chimera” and excluded from further analysis. For the resequencing
reproducibility evaluation, chimera detection analysis was not
performed.
Selected HPV-related sequences that were 90% identical to each
other over 90% of their length were clustered using the Cd-hit
algorithm (Li and Godzik, 2006) and one representative sequence
was selected from each cluster to remove redundancy. HPV-
related sequences, which had less than 90% identity over 90% of
their length to known HPV genomes, were classiﬁed as putatively
new HPV types.
Phylogenetic analysis
PhyML v3 (Guindon and Gascuel, 2003) was used to construct a
maximum likelihood tree. ModelTest v3.7 (Posada and Crandall,
1998) identiﬁed a GTRþ IþG substitution model as the best ﬁt
model based on the Akaike Information Criterion.
The analyses were restricted to sequences that were complete
or almost complete fragments or contained 4200 bp of the 5′-of
end of the amplimer, to avoid the possibility that non-overlapping
sequences might derive from the same virus.
The novel HPV DNA sequences have been deposited in GenBank
under the following accession numbers: SE2, JQ250743; SE6,
JQ250756; SE8, JQ250773; SE21, JN129832; SE48, JQ250744; SE49,
JQ250745; SE50, JQ250746; SE51, JQ250747; SE52, JQ250748; SE53,
JQ250749; SE54, JQ250750; SE55, JQ250751; SE56, JQ250752; SE57,
JQ250753; SE58, JQ250754; SE59, JQ250755; SE61, JQ250757; SE62,
JQ250758; SE63, JQ250759; SE64, JQ250760; SE65, JQ250761; SE67,
JQ250762; SE68, JQ250763; SE69, JQ250764; SE70, JQ250765; SE71,
JQ250766; SE72, JQ250767; SE73, XXX SE74, JQ250768; SE75,
JQ250769; SE77, JQ250770; SE78, JQ250771; SE79, JQ250772; SE80,
JX316020; SE81, JX316021; SE82, JX316022; SE83, JX316023; SE84,
JX316024; SE85, KC107232; SE86, JX316025; SE117,KC878001; SE118,
KC878002; SE119,KC878003; SE120,KC878004; SE121,KC878005; SE1
22,KC878006; SE123,KC878007; SE124,KC878008; SE125,KC878009;
SE126,KC878010; SE127,KC878011 and SE128,KC878012.
Luminex
Unique probes were designed for each of 44 novel subgenomic
sequences (SE1-SE44) (Supplementary Table 1). There was no
consistent pattern of cross-reactivity with any particular probe
when samples were positive for the different viruses, except for
the probe for SE44 that had unspeciﬁc hybridization and was
therefore excluded from analysis. Each probe (DNA technology,
Denmark) was covalently linked to ﬂuorescence-labeled carboxy-
coated polystyrene beads (BioRad, Sweden) as previously described
(Schmitt et al., 2006), with some modiﬁcations. In short, 12.5
million carboxylated beads were suspended in 125 ml of 0.1 M 2-
(N-morpholino) ethanesulfonic acid, pH 4.5 (MES), after which
2 nmol of probes and 1 mg of N-(3-dimethylaminopropyl)-N-ethyl-
carbodiimide (EDC) were added, and the mix was incubated for
30 min under agitation in the dark. After repeated addition of EDC
followed by incubation, the beads were ﬁrst washed with 1.5 ml of
0.02% Tween 20 and then with 1.5 ml of 0.1% sodium dodecyl
sulphate before storage in 500 ml of TE buffer at 4 1C. Biotinylated
amplicons in 10 ml aliquots from the FAP PCR reaction were
hybridized to the probes on the Bioplex 200 Luminex system
(Bio-Rad, Sweden), as previously described (Schmitt et al., 2006)
but with a hybridization temperature of 50 1C and with a resuspen-
sion of beads for 30 min in 70 ml of streptavidin-R-phycoerytrin
(Invitrogen, Sweden). Water and 10 ng/ml of human DNA (Sigma,
Sweden) in Tris-EDTA buffer were negative controls. Cutoff was
determined for each probe by adding the mean of the median
ﬂuorescence intensity (MFI) of the water controls to ﬁve times the
standard deviation of these MFIs, with a minimum cutoff set to
three MFIs. All positive samples were re-analysed and only repea-
table results were considered positive. In case of discrepancy, the
analysis was repeated and the result from two out of three analyses
was used.
We ﬁrst applied the Luminex assay for the 44 putatively new
HPV types to 331 samples (fresh frozen biopsies from 30 SCCs,
33 AKs and 92 KAs; swab samples from the top of 84 SCCs and 92
AKs (15)) from the pools where the 44 putatively new types had
been detected (12 samples that had been included in the pools
were no longer available). In this validation step, the samples in
each pool were only tested for the sequences detected in that
speciﬁc pool. Subsequently, an additional 592 samples from 296
patients were screened in the Luminex assay (fresh frozen biopsies
from 67 SCCs, 117 BCCs, 56 AKs, 8 KAs and 48 benign lesions as
well as a healthy skin biopsy from each patient) for all sequences
detected in the three pools.
J. Ekström et al. / Virology 447 (2013) 300–311 309
Samples diluted 1:2 in TE buffer (10 mM Tris–HCl, 0.1 mM
EDTA, pH 8.0) were ampliﬁed using FAP primers (Cybergene,
Sweden) as described, using a 5 ml input volume from each sample
(Forslund et al., 1999). All forward primers were biotinylated at the
5′ end.
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